These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 28038704)

  • 21. Can GATA3 Immunocytochemistry be Utilized as a Reliable Diagnostic Marker for Metastatic Breast Carcinoma in Cytological Materials? A Comparative Study with Mammaglobin and GCDFP-15 Expression.
    Hafez NH; Shaaban HM
    Turk Patoloji Derg; 2018; 34(2):143-149. PubMed ID: 29235613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SOX10, GATA3, GCDFP15, Androgen Receptor, and Mammaglobin for the Differential Diagnosis Between Triple-negative Breast Cancer and TTF1-negative Lung Adenocarcinoma.
    Laurent E; Begueret H; Bonhomme B; Veillon R; Thumerel M; Velasco V; Brouste V; Hoppe S; Fournier M; Grellety T; MacGrogan G
    Am J Surg Pathol; 2019 Mar; 43(3):293-302. PubMed ID: 30628926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas.
    Luo MH; Huang YH; Ni YB; Tsang JY; Chan SK; Shao MM; Tse GM
    Hum Pathol; 2013 Jul; 44(7):1241-50. PubMed ID: 23332923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heat shock protein 27 and gross cystic disease fluid protein 15 play critical roles in molecular apocrine breast cancer.
    Liu X; Feng C; Liu J; Zhao L; Liu J; Zhang W; Liu N; Niu Y
    Tumour Biol; 2016 Jun; 37(6):8027-36. PubMed ID: 26711786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistological expression of oestrogen receptor, progesterone receptor, mammaglobin, human epidermal growth factor receptor 2 and GATA-binding protein 3 in non-small-cell lung cancer.
    Kriegsmann K; Zgorzelski C; Muley T; Christopoulos P; von Winterfeld M; Herpel E; Goeppert B; Mechtersheimer G; Sinn P; Stenzinger A; Schirmacher P; Winter H; Eichinger M; Warth A; Kriegsmann M
    Histopathology; 2020 Dec; 77(6):900-914. PubMed ID: 32634256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GATA3 as a putative marker of breast cancer metastasis-A retrospective immunohistochemical study.
    De Lara S; Parris TZ; Werner Rönnerman E; Helou K; Kovács A
    Breast J; 2018 Mar; 24(2):184-188. PubMed ID: 28703335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significantly increased PELP1 protein expression in primary and metastatic triple-negative breast carcinoma: comparison with GATA3 expression and PELP1's potential role in triple-negative breast carcinoma.
    Dang DN; Raj G; Sarode V; Molberg KH; Vadlamudi RK; Peng Y
    Hum Pathol; 2015 Dec; 46(12):1829-35. PubMed ID: 26428280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating the utility of trefoil factor 1 as a mammary-specific immunostain compared and in conjunction with GATA-3 and mammaglobin in the distinction between carcinoma of breast and lung.
    Wells JM; Ginter PS; Liu Y; Chen Z; Narula N; Shin SJ
    Am J Clin Pathol; 2015 Sep; 144(3):444-51. PubMed ID: 26276775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative expression of TRPS1, GATA3, SOX10, mammaglobin, and GCDFP-15 in effusion specimens with breast carcinoma.
    Bradt A; Jing X; Smola BS; Lew M
    Diagn Cytopathol; 2023 Nov; 51(11):665-673. PubMed ID: 37461248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammaglobin, GATA-binding protein 3 (GATA3), and epithelial growth factor receptor (EGFR) expression in different breast cancer subtypes and their clinical significance.
    Kong X; Wang Q; Li J; Li M; Deng F; Li C
    Eur J Histochem; 2022 Apr; 66(2):. PubMed ID: 35388661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strong androgen receptor expression can aid in distinguishing GATA3+ metastases.
    Boto A; Harigopal M
    Hum Pathol; 2018 May; 75():63-70. PubMed ID: 29408697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer.
    Huo L; Zhang J; Gilcrease MZ; Gong Y; Wu Y; Zhang H; Resetkova E; Hunt KK; Deavers MT
    Histopathology; 2013 Jan; 62(2):267-74. PubMed ID: 22963676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry.
    Huo L; Gong Y; Guo M; Gilcrease MZ; Wu Y; Zhang H; Zhang J; Resetkova E; Hunt KK; Deavers MT
    Histopathology; 2015 Aug; 67(2):245-54. PubMed ID: 25564996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of GATA-3 in the work-Up of breast adenocarcinoma and its differential diagnosis in serous effusions:: A Cell-Block Microarray Study.
    El Hag MI; Ha J; Farag R; El Hag AM; Michael CW
    Diagn Cytopathol; 2016 Sep; 44(9):731-6. PubMed ID: 27338760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The utility of villin and mammaglobin in the differential diagnosis between intrahepatic cholangiocarcinoma and breast cancer.
    Yang Z
    Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):19-25. PubMed ID: 25153498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases.
    Espinosa I; Gallardo A; D'Angelo E; Mozos A; Lerma E; Prat J
    Int J Gynecol Pathol; 2015 May; 34(3):257-65. PubMed ID: 25844549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous and mammary apocrine carcinomas have different immunoprofiles.
    Piris A; Peng Y; Boussahmain C; Essary LR; Gudewicz TM; Hoang MP
    Hum Pathol; 2014 Feb; 45(2):320-6. PubMed ID: 24342430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TRPS1 expression in cytokeratin 5 expressing triple negative breast cancers, its value as a marker of breast origin.
    Almási S; Kuthi L; Sejben A; Vörös A; Nagy Á; Zombori T; Cserni G
    Virchows Arch; 2023 May; 482(5):861-868. PubMed ID: 37012444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRPS1 and GATA3 Expression in Invasive Breast Carcinoma With Apocrine Differentiation.
    Wang J; Peng Y; Sun H; Aung PP; Resetkova E; Yam C; Sahin AA; Huo L; Ding Q
    Arch Pathol Lab Med; 2024 Feb; 148(2):200-205. PubMed ID: 37074839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic breast carcinoma in pleural fluid: Correlation of receptor and HER2 status with the primary carcinoma-a pilot study.
    Francis IM; Alath P; George SS; Jaragh M; Al Jassar A; Kapila K
    Diagn Cytopathol; 2016 Dec; 44(12):980-986. PubMed ID: 27666130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.